{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:37:58Z","timestamp":1761154678926},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":5668,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1093\/annonc\/mdh281","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T19:14:50Z","timestamp":1087499690000},"page":"993-995","source":"Crossref","is-referenced-by-count":10,"title":["HIV-related non-Hodgkin's lymphoma (HIV-NHL) in the era of highly active antiretroviral therapy (HAART): some still unanswered questions for clinical management"],"prefix":"10.1016","volume":"15","author":[{"given":"M.","family":"Spina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh281_bb0010","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared to standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh281_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-9343(93)90259-R","article-title":"Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy: French\u2013Italian Cooperative Group","volume":"95","author":"Gisselbrecht","year":"1993","journal-title":"Am J Med"},{"key":"10.1093\/annonc\/mdh281_bb0020","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh281_bb0025","first-page":"478","article-title":"Systemic non-Hodgkin's lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival","volume":"30","author":"Gerard","year":"2002","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mdh281_bb0030","first-page":"281a","article-title":"Highly active antiretroviral therapy (HAART) significantly improves disease free survival (DFS) in patients (Pts) with HIV-related non-Hodgkin\u2019s lymphoma (HIV-NHL) treated with chemotherapy (CT)","volume":"20","author":"Vaccher","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdh281_bb0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh281_bb0040","doi-asserted-by":"crossref","first-page":"A53","DOI":"10.1097\/00042560-199704010-00191","article-title":"Therapy of HIV-related non-Hodgkin\u2019s lymphoma: an European multicentric randomized study in patients stratified according to their prognostic factors: preliminary results","volume":"14","author":"Gisselbrecht","year":"1997","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1093\/annonc\/mdh281_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh281_bb0050","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1200\/JCO.1996.14.11.3026","article-title":"A pilot trial of infusional cyclophosphamide, doxorubicin and etoposide plus didanosine and filgrastim in patients with HIV-associated non-Hodgkin's lymphoma","volume":"14","author":"Sparano","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh281_bb0055","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh281_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-200301030-00024","article-title":"Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection","volume":"17","author":"Spina","year":"2003","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mdh281_bb0065","article-title":"CHOP chemotherapy plus rituximab in HIV patients with high grade lymphoma\u2014Results of an ANRS trial. Proc Am Soc Hematol2002; 470a","author":"Bou\u00e9","year":"1824","journal-title":"(Abstr"},{"key":"10.1093\/annonc\/mdh281_bb0070","first-page":"564","article-title":"for the AIDS Malignancies Consortium. No benefit from rituximab in a randomized phase III trial of CHOP with or without rituximab for patients with HIV-associated non-Hodgkin\u2019s lymphoma: AIDS malignancies consortium study 010","volume":"22","author":"Kaplan","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdh281_bb0075","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh281_bb0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/hon.715","article-title":"Long-term survival in patients with human immunodeficiency virus-associated small non-cleaved cell lymphoma: the role of short course intensive chemotherapy","volume":"21","author":"Astrow","year":"2003","journal-title":"Hematol Oncol"},{"key":"10.1093\/annonc\/mdh281_bb0085","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh281_bb0090","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2127::AID-CNCR25>3.0.CO;2-W","article-title":"Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone and prednimustine in relapsed patients","volume":"77","author":"Tirelli","year":"1996","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh281_bb0095","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.1997.15.3.1094","article-title":"Mitoguazone therapy in patients with refractory or relapsed AIDS-realted lymphoma: results from a multicenter phase II trial","volume":"15","author":"Levine","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh281_bb0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1097-0142(20010701)92:1<200::AID-CNCR1310>3.0.CO;2-A","article-title":"Human immunodeficiency virus-related non-Hodgkin's lymphoma: activity of infusional cyclophosphamide, doxorubicin and etoposide as second-line chemotherapy in 40 patients","volume":"92","author":"Spina","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh281_bb0105","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(00)02041-9","article-title":"High-dose chemotherapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma","volume":"355","author":"Gabarre","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdh281_bb0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0268-960X(03)00026-2","article-title":"Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation","volume":"17","author":"Molina","year":"2003","journal-title":"Blood Rev"},{"key":"10.1093\/annonc\/mdh281_bb0115","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1200\/JCO.2003.06.039","article-title":"High-dose therapy and autologous peripheral-blood stem-cell (PBSC) transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy","volume":"21","author":"Re","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419480381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419480381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/7\/993\/679096\/mdh281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T17:01:30Z","timestamp":1582218090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419480381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0923753419480381"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh281","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}